This invention relates generally to medical technology and more particularly to a method and apparatus for implanting an elongate conduit, e.g., a catheter or cable, to extend through a patient's skin for providing long term access to an interior body site. Embodiments of the invention are useful in a variety of applications, e.g., in hemodialysis procedures to enable a catheter to provide fluid access to a patient's central venous system and/or nerve stimulation procedures in which a cable provides access to an implanted electric device.
In a variety of medical procedures, catheters are percutaneously implanted, i.e., through a patient's skin, to provide long term access to interior body sites; e.g., blood vessels and organs. Unless adequate precautions are taken, infections and inflammation can readily occur at the catheter entry site. To mitigate such problems, a tissue integrating cuff is sometimes attached to the catheter and placed under the patient's skin to resist infection. Although such a cuff can reduce the likelihood of infection, once ingrown its presence increases the difficulty of removing and/or repositioning an implanted catheter. More particularly, it is not uncommon for an implanted catheter to become damaged, e.g., clogged or kinked, over an extended period of use thus necessitating catheter removal and/or replacement. When this occurs, the cuff must be dissected thereby complicating and prolonging the surgical procedure.
The aforementioned parent application Ser. No. 11/708,445 describes a medical apparatus and method which enables an elongate conduit, e.g., a catheter or cable, to be percutaneously implanted in a manner which allows the conduit to be readily positioned, repositioned, and replaced. A preferred embodiment described in said parent application includes a sleeve carrying a tissue integrating porous layer proximate to the sleeve distal end. The sleeve distal end is intended for insertion through a skin incision to subcutaneously locate the porous layer in contact with the patient's dermis for promoting soft tissue ingrowth. Such tissue ingrowth functions to anchor the sleeve and create an infection resistant barrier. The preferred embodiment described in said parent application preferably also includes a protective sheath overlaying the porous layer to avoid injuring incision adjacent tissue as the sleeve distal end is inserted through the incision. The sheath is removed from the sleeve by the physician after the porous layer has passed through the incision.
The aforementioned parent application Ser. No. 12/287,130 describes an apparatus and method for implanting a medical device through an incision which is intentionally undersized relative to the lateral dimension, i.e., width or diameter, of the device porous layer to enhance cell proliferation and healing.
The present invention is directed to an enhanced medical apparatus embodiment for more conveniently percutaneously implanting an elongate conduit, e.g., a catheter or cable, in a manner which both avoids tissue injury as the apparatus is implanted and allows the conduit to be easily positioned, repositioned, and replaced. The apparatus includes an elongate tubular sleeve having a forward portion whose outer surface is tapered to dilate a patient's skin incision as the sleeve is inserted therethrough. The sleeve includes an interior axial passageway through which the conduit is able to slide.
A preferred embodiment in accordance with the present invention is particularly configured to simplify implantation and avoid injury to the patient's incision adjacent tissue. More particularly, the preferred embodiment includes an elongate tubular sleeve formed of biocompatible material, e.g., titanium, having a tapered forward portion, extending proximally from a sleeve distal end to a lateral shoulder surface. The tapered forward portion has a smooth outer surface which gradually increases in lateral dimension, i.e., width or diameter, from D1 near its distal end to D2 near the shoulder surface. A rearward sleeve portion extending proximally from the shoulder surface defines an outer lateral dimension D3, where D3 is less than D2. In accordance with the present invention, the rearward portion carries a layer of porous material, e.g., a biocompatible mesh, near the shoulder surface forming an outer diameter D4 where D4 is preferably slightly less than D2.
The aforedescribed configuration permits the sleeve to be implanted through a single minimally sized incision while avoiding injury to incision adjacent tissue which might otherwise be caused as the porous material passes through the incision. More particularly, it is preferable to provide an intentionally undersized incision (i.e., approximately 10-20% smaller than D4) for receiving the sleeve distal end, as is taught in applicant's aforementioned parent application Ser. No. 12/287,130. In use, as the sleeve forward portion is inserted through the incision, the smooth tapered surface gently elastically stretches, or dilates, the patient's adjacent tissue to a diameter D2 allowing the porous material to pass through the incision without abrading or otherwise injuring the incision adjacent tissue.
The sleeve interior axial passageway is dimensioned to snugly accommodate the outer surface of a conduit (which will hereinafter be assumed to be a catheter unless otherwise stated) while permitting the conduit to slide and rotate in the passageway relative to the sleeve. A sealing device within the sleeve extends around the catheter, e.g., near the sleeve proximal end, to prevent deleterious material from migrating into the patient's body along the catheter outer surface. The sealing device preferably comprises an annular seal formed of a soft flexible material, e.g., silicone, mounted within the sleeve passageway. The annular seal comprises a peripheral wall having an outer surface and an inner surface surrounding an interior bore. At least one annular flexible nib on the seal inner surface projects radially into the bore for sealing against the catheter outer surface. Although the sleeve preferably comprises a rigid titanium tube, alternatively, the sleeve can be formed of flexible tubing, e.g., silicone, allowing an interior annular sealing nib to be formed integral therewith.
The preferred embodiment also includes a locking member hinged to the anchor device mounted near the sleeve proximal end. The locking member can be readily pivoted between a first, or locked, position surrounding the conduit and a second, or unlocked, position remote from the conduit. In the unlocked position, the catheter is able to slide and/or rotate relative to the sleeve passageway. In the locked position, the locking member is able to apply a friction force to the catheter outer surface to prevent relative movement between the catheter and the sleeve. A preferred locking member comprises a split ring formed of a soft flexible material, e.g., silicone which, in the locked position, can be radially compressed to frictionally grip the catheter outer surface to prevent catheter movement relative to the sleeve. The split ring can be compressed in various ways; e.g., by simply tying it with suture thread or by using an internal or external clip, e.g., spring urged clamp, to pinch the split ring.
In a preferred procedure, a physician will make a controlled incision having a width approximately 10-20% less than D4, near the patient's chest or abdomen. A surgical tunneler tool is then typically inserted through the incision, to form a subcutaneous tunnel to an interior site through which a standard flexible catheter can be inserted and positioned. In accordance with the invention, the catheter carries the aforementioned sleeve and functions to guide the sleeve distal end through the undersized incision to place the sleeve porous layer in contact with the patient's dermis beneath the patient's outer skin surface. The sleeve proximal end is then preferably externally anchored to the patient's skin. With the locking member in its unlocked position, the physician is able to slide and/or rotate the catheter relative to the sleeve and locking member for optimum catheter tip positioning. When the catheter is properly positioned, the physician can then pivot the locking member to the locked position and then compress it to grip the catheter outer surface. With the sleeve thus implanted, the patient's subcutaneous tissue will, over time, grow into the porous material to anchor the sleeve and form an infection resistant barrier. The porous material, and/or sleeve interior, can be coated or impregnated with constituents having antimicrobial and/or anti-inflammatory properties, e.g., silver containing compounds or antibiotic eluting coatings and/or steroids, to further promote healing.
Various medical regimens relating, for example, to hemodialysis drug infusion, plasmapheresis, etc., use a percutaneously implanted conduit for conveying fluid and/or electric signals to/from an interior body site. The present invention is directed to a method and apparatus for facilitating the implantation and utilization of a percutaneous conduit (e.g., catheter) and for facilitating the positioning, repositioning, and replacement, or exchange, of the catheter.
Attention is now directed to
The sleeve 30 preferably comprises a substantially rigid tubular titanium member formed by a peripheral wall 36 having an outer surface 37 and an inner surface 38. As can be best seen in
The sleeve inner surface 38 surrounds an interior passageway 54 extending axially from the sleeve proximal end 44 to the sleeve distal end 42.
The outer peripheral surface 62 of bulbous section 48 is dimensioned to closely fit into bore 72 of anchor 35. The anchor 35 (
The locking member 33 preferably comprises a split ring 80 formed of soft flexible material, e.g., silicone. More particularly, the locking member 33 is comprised of a peripheral wall 82 having an outer surface 84 and an inner surface 86 surrounding an interior bore. The wall 82 is longitudinally split at 90 to form opposed edges 92, 93. The wall outer surface 84 is preferably provided with one or more pads 94 for attaching the aforementioned hinge members 34, as by adhesive 95. The hinge members 34 preferably comprise flexible straps which are also adhered to the outer surface of anchor 35, as can be best seen in
In use, it is intended that the sleeve forward portion 40 be inserted through an incision 24 in the patient's skin to position the porous layer 31 beneath the patient's epidermis skin layer (
A preferred catheter assembly in accordance with
In an alternative embodiment, the sleeve can be similarly dimensioned but instead of being formed of a rigid material such as titanium, can be formed of a flexible material such as silicone. In such an embodiment, the annular sealing nibs can be integrally formed with the sleeve.
In order to assist the physician to form a closely dimensioned undersized opening in accordance with the invention, it is preferable to provide a surgical cutting tool having a cutting edge dimensioned to the desired opening size.
In use, a physician will incise the patient's skin with the blade point 138 by pushing the blade straight inwardly until stopped by face 128. That is, the spacing between pointed end 138 and face 128 will define the depth (e.g., 0.39″) of the incision 24 formed by the blade 130. By pushing straight inwardly, the physician is able to create a clean closely dimensioned incision 24 to form opening 100. Preferably the blade width is selected to be between about 80 and 90% of the lateral dimension of the device to be inserted. The physician will then manually stretch the skin around opening 100 and insert the dilating forward portion 40 to place porous layer 31 adjacent the patient's dermis. After placement and after termination of the manual stretching, the surrounding tissue will elastically retract against the porous layer but will remain physically stressed by the relatively oversized device. The residual stress, or tension, in the surrounding tissue acts to stimulate healing and promote tissue ingrowth into the porous layer 31. In addition to the effects of circumferential strain on cellular proliferation, extracellular matrix deposition, or hypoxic signaling upregulating angiogenic response, an undersized incision in accordance with the invention may decrease the volume of the underlying subcutaneous pocket thus stabilizing the implanted device and reducing foreign body response to movement of the device.
After initial implantation of the catheter 22, it is sometimes desirable to reposition the catheter for more effective treatment and/or to reduce patient discomfort. Such repositioning can involve slightly adjusting the position and/or orientation of the catheter distal end and is achieved by pivoting the locking member 33 to the unlocked position (
It is further pointed out that with the locking member 33 in its unlocked position, an implanted catheter can be fully withdrawn through the sleeve proximal end for replacement by a new catheter. Although different techniques can be employed, it is contemplated that the physician will thread a guide wire through the old catheter prior to withdrawing it. The new catheter is then threaded along the guide wire and through the sleeve. When the new catheter is properly placed, the guide wire is typically withdrawn.
From the foregoing, it should now be understood that a catheter assembly has been provided particularly configured to facilitate the positioning, repositioning, and/or replacement of a percutaneously implanted catheter. Although only a limited number of structural embodiments have been described, it is recognized that various modifications and alterations will occur to persons skilled in the art which fall within the spirit and intended scope of the invention as defined by the appended claims
This application is a Continuation-In-Part of (1) U.S. application Ser. No. 11/708,445 filed on Feb. 20, 2007 now U.S. Pat. No. 7,731,697 which claims priority based on U.S. Provisional Application 60/818,768 filed on Jul. 5, 2006 and (2) U.S. application Ser. No. 12/287,130 filed on Oct. 6, 2008 which claims priority based on U.S. Provisional Application 60/999,480 filed on Oct. 17, 2007. This application claims priority based on the aforementioned applications which are by reference incorporated herein.
Number | Name | Date | Kind |
---|---|---|---|
3447161 | Weikel | Jun 1969 | A |
3683911 | McCormick | Aug 1972 | A |
3783868 | Bokros | Jan 1974 | A |
4147164 | Behney | Apr 1979 | A |
4278092 | Borsanyi et al. | Jul 1981 | A |
4379506 | Davidson | Apr 1983 | A |
4417888 | Cosentino et al. | Nov 1983 | A |
4488877 | Klein et al. | Dec 1984 | A |
4496349 | Cosentino | Jan 1985 | A |
4540411 | Bodicky | Sep 1985 | A |
4592749 | Ebling et al. | Jun 1986 | A |
4648391 | Ellis | Mar 1987 | A |
4668222 | Poirier et al. | May 1987 | A |
4728331 | Russier | Mar 1988 | A |
4729366 | Schaefer | Mar 1988 | A |
4781693 | Martinez et al. | Nov 1988 | A |
4781694 | Branemark et al. | Nov 1988 | A |
4828560 | Heyler, III | May 1989 | A |
4886502 | Poirier et al. | Dec 1989 | A |
4897081 | Poirier et al. | Jan 1990 | A |
5007897 | Kalb et al. | Apr 1991 | A |
5041085 | Osborne et al. | Aug 1991 | A |
5085646 | Svenson et al. | Feb 1992 | A |
5098434 | Serbousek | Mar 1992 | A |
5109875 | Gottlieb | May 1992 | A |
5221263 | Sinko et al. | Jun 1993 | A |
5318040 | Kensey et al. | Jun 1994 | A |
5360397 | Pincuck | Nov 1994 | A |
5370698 | Heimke et al. | Dec 1994 | A |
5407354 | Fife | Apr 1995 | A |
5411467 | Hortmann et al. | May 1995 | A |
5715815 | Lorenzen et al. | Feb 1998 | A |
5885217 | Gisselberg et al. | Mar 1999 | A |
5931838 | Vito | Aug 1999 | A |
6099508 | Bousquet | Aug 2000 | A |
6332874 | Eliasen et al. | Dec 2001 | B1 |
6334862 | Vidal et al. | Jan 2002 | B1 |
6520939 | Lafontaine | Feb 2003 | B2 |
6544206 | Johnston, Jr. | Apr 2003 | B1 |
6896689 | Gedebou | May 2005 | B2 |
6916310 | Sommerich | Jul 2005 | B2 |
6955677 | Dahners | Oct 2005 | B2 |
20020072712 | Nool et al. | Jun 2002 | A1 |
20020107475 | Maginot | Aug 2002 | A1 |
20030149422 | Muller | Aug 2003 | A1 |
20030199827 | Thorne | Oct 2003 | A1 |
20040111138 | Bleam et al. | Jun 2004 | A1 |
20040204686 | Porter et al. | Oct 2004 | A1 |
20050059925 | Maginot et al. | Mar 2005 | A1 |
20060030817 | Kraus et al. | Feb 2006 | A1 |
20070149949 | Porter et al. | Jun 2007 | A1 |
20070213675 | Albrecht et al. | Sep 2007 | A1 |
20080108969 | Kerr | May 2008 | A1 |
Number | Date | Country |
---|---|---|
0367354 | Feb 1993 | EP |
2268066 | Jan 1994 | GB |
WO9315664 | Aug 1993 | WO |
Number | Date | Country | |
---|---|---|---|
20090171295 A1 | Jul 2009 | US |
Number | Date | Country | |
---|---|---|---|
60818768 | Jul 2006 | US | |
60999480 | Oct 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12287130 | Oct 2008 | US |
Child | 12321962 | US | |
Parent | 11708445 | Feb 2007 | US |
Child | 12287130 | US |